Atıf İçin Kopyala
Karatas H., ALP M., Yildiz S., GÖKER A. H.
CHEMICAL BIOLOGY & DRUG DESIGN, cilt.80, sa.2, ss.237-244, 2012 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
80
Sayı:
2
-
Basım Tarihi:
2012
-
Doi Numarası:
10.1111/j.1747-0285.2012.01393.x
-
Dergi Adı:
CHEMICAL BIOLOGY & DRUG DESIGN
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.237-244
-
Anahtar Kelimeler:
1H-Benzimidazole, antifungal and antibacterial activities, benzamide, benzamidine, methicillin-resistant Staphylococcus aureus, ANTIMICROBIAL ACTIVITY, STAPHYLOCOCCUS-AUREUS, ANTIBACTERIAL AGENTS, VRE AGENTS, BENZIMIDAZOLES
-
Ankara Üniversitesi Adresli:
Evet
Özet
A new class of 1H-benzimidazolecarboxamidines was synthesized and evaluated for in vitro antibacterial and antifungal activities, including drug-resistant bacterial strains. The most potent compound (32) has the same ratio of anti-MRSA activity as Vancomycin (minimal inhibitory concentrations value 0.78 mu mu g/mL). The mechanism of action for 1H-benzimidazolecarboxamidine appears to be different from existing antibacterial agents. These compounds have potential for development as a new class of potent anti-MRSA agent.